A collaborative American research group, led by Prof Aaron Gitler from Stanford University School of Medicine in California, has identified a potential therapeutic target for MND using yeast. The toxic activity of the MND-linked protein TDP-43 was suppressed when a gene called DBR1 was deleted from yeast and mammal cells.The study marks the first steps in the identification of a treatment that can target TDP-43, which is found to clump together in over 90% of cases of MND. Read more on the MND Research Blog

Subscribe to news and updates